Lista de obras - Michael Krainer - Dominio Público Uruguay

32nd International Austrian Winter Symposium : Zell am See, the Netherlands. 20-23 January 2016

artículo científico publicado en 2016

A prospective, open label, randomized phase II trial of weekly docetaxel versus weekly vinorelbine as first line chemotherapy in patients with androgen independent prostate cancer

artículo científico publicado en 2007

Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.

artículo científico publicado en 2010

BAMBI is overexpressed in ovarian cancer and co-translocates with Smads into the nucleus upon TGF-beta treatment

artículo científico publicado en 2010

Chemotherapy for prostate cancer

artículo científico publicado en 2008

Circulating endothelial progenitor cells in castration resistant prostate cancer: a randomized, controlled, biomarker study

artículo científico publicado en 2014

Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database

scientific article published on 29 November 2019

Common death receptor 4 (DR4) polymorphisms do not predispose to ovarian cancer

artículo científico publicado en 2005

Common nonsense mutations in RAD52

artículo científico publicado en 1999

Contribution of epigenetic silencing of tumor necrosis factor-related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancer

artículo científico publicado en 2005

Decreased expression of ICAM-1 and its induction by tumor necrosis factor on breast-cancer cells in vitro

scientific article published on 01 June 1997

Difference in patient's acceptance of early versus late initiation of psychosocial support in breast cancer.

artículo científico publicado en 2001

Differential Contributions ofBRCA1andBRCA2to Early-Onset Breast Cancer

artículo científico publicado en 1997

Distinctive outcome in patients with non-uterine and uterine leiomyosarcoma.

artículo científico publicado en 2014

Docetaxel as rescue medication in anthracycline- and ifosfamide-resistant locally advanced or metastatic soft tissue sarcoma: results of a phase II trial

artículo científico publicado en 2001

Docetaxel rechallenge after an initial good response in patients with metastatic castration-resistant prostate cancer.

artículo científico publicado en 2014

Dose intensification of epidoxorubicin and cyclophosphamide in metastatic breast cancer: a randomised study with two schedules of granulocyte-macrophage colony stimulating factor

scientific article published on 01 March 1998

Epidermal growth factor receptor degradation: an alternative view of oncogenic pathways.

artículo científico publicado en 2007

Erythropoietin treatment for chronic anemia of selected hematological malignancies and solid tumors

scientific article published on 01 February 1993

Erythropoietin treatment of chronic anaemia of cancer

scientific article published on 01 January 1993

Failure to confirm presence of SV40 sequences in human tumours.

artículo científico publicado en 1995

Five genes from chromosomal band 8p22 are significantly down-regulated in ovarian carcinoma: N33 and EFA6R have a potential impact on overall survival

artículo científico publicado en 2005

Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families

artículo científico publicado en 1996

Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer

artículo científico publicado en 1996

HCRP1 expression status is a significant prognostic marker in oral and oropharyngeal cancer

artículo científico publicado en 2012

HIF1α Regulates mTOR Signaling and Viability of Prostate Cancer Stem Cells

artículo científico publicado en 2014

High frequency of allelic imbalance at regions of chromosome arm 8p in ovarian carcinoma.

artículo científico publicado en 2001

Hyperreactive cellular immunity in multiple myeloma

artículo científico publicado en 1992

Immune checkpoint inhibitors in mCRPC - rationales, challenges and perspectives

artículo científico publicado en 2019

In ovarian cancer the prognostic influence of HER2/neu is not dependent on the CXCR4/SDF-1 signalling pathway.

artículo científico publicado en 2007

In vivo administration of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor increases neutrophil oxidative burst activity

scientific article published on 01 March 1995

Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome

artículo científico publicado en 1998

Increase of bone marrow cellularity during erythropoietin treatment in myeloma

scientific article published on 01 August 1995

Increased natural killer cell activity correlates with low or negative expression of the HER-2/neu oncogene in patients with breast cancer

artículo científico publicado en 1994

Influence of etoposide on the retention of radiolabeled low-density lipoprotein in the arterial wall

artículo científico publicado en 1999

Influence of in vivo administration of GM-CSF and G-CSF on monocyte cytotoxicity

artículo científico publicado en 1995

Interleukin-6 is a prognostic factor in multiple myeloma

artículo científico publicado en 1991

Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial

artículo científico publicado en 2014

Linking the ovarian cancer transcriptome and immunome

artículo científico publicado en 2008

Loss of the oligosaccharyl transferase subunit TUSC3 promotes proliferation and migration of ovarian cancer cells.

artículo científico publicado en 2013

Methylation status of TUSC3 is a prognostic factor in ovarian cancer

artículo científico publicado en 2012

Monitoring of serum Her-2/neu predicts histopathological response to neoadjuvant trastuzumab-based therapy for breast cancer.

artículo científico publicado en 2004

Monitoring of serum Her-2/neu predicts response and progression-free survival to trastuzumab-based treatment in patients with metastatic breast cancer

artículo científico publicado en 2004

Natural killer cell activity in long-term survivors of testicular cancer. Influence of cytostatic therapy and initial stage of disease

artículo científico publicado en 1995

Oncogenic BARD1 isoforms expressed in gynecological cancers

artículo científico publicado en 2007

Perturbation of the tumor necrosis factor--related apoptosis-inducing ligand cascade in ovarian cancer: overexpression of FLIPL and deregulation of the functional receptors DR4 and DR5.

artículo científico publicado en 2005

Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1.

artículo científico publicado en 2016

Physical map and cosmid contig encompassing a new interstitial deletion of the X-linked lymphoproliferative syndrome region

artículo científico publicado en 1996

Predictive value of interleukin-6 and neopterin in patients with multiple myeloma

scientific article published on 01 December 1991

Promoter hypermethylation of GSTP1, AR, and 14-3-3sigma in serum of prostate cancer patients and its clinical relevance

artículo científico publicado en 2007

Rad52 gene mutations in breast/ovarian cancer families and sporadic ovarian carcinoma patients.

artículo científico publicado en 2003

Recurrence-free survival in prostate cancer is related to increased stromal TRAIL expression.

artículo científico publicado en 2010

Resistance to TRAIL-induced apoptosis in ovarian cancer cell lines is overcome by co-treatment with cytotoxic drugs.

artículo científico publicado en 2004

Second consensus on medical treatment of metastatic breast cancer

artículo científico publicado en 2006

Sequencing of Taxanes and New Androgen-targeted Therapies in Metastatic Castration-resistant Prostate Cancer: Results of the International Multicentre Retrospective CATS Database

artículo científico publicado en 2018

Single-agent trastuzumab versus trastuzumab plus cytotoxic chemotherapy in metastatic breast cancer: a single-institution experience

artículo científico publicado en 2005

Soluble HER-2/neu neutralizes biologic effects of anti-HER-2/neu antibody on breast cancer cells in vitro

artículo científico publicado en 1997

Soluble ICAM-1 in breast cancer: clinical significance and biological implications.

artículo científico publicado en 2001

TUSC3 loss alters the ER stress response and accelerates prostate cancer growth in vivo

artículo científico publicado en 2014

Targeting signaling pathways in ovarian cancer.

artículo científico publicado en 2008

Technetium-99m-tetrofosmin scintigraphy in patients with metastatic soft tissue sarcoma.

artículo científico publicado en 2002

The European Society for Medical Oncology Magnitude of Clinical Benefit Scale in daily practice: a single institution, real-life experience at the Medical University of Vienna.

artículo científico publicado en 2016

The Prognostic Value of C-Reactive Protein Serum Levels in Patients with Uterine Leiomyosarcoma.

artículo científico publicado en 2015

The medical management of prostate cancer: a multidisciplinary team approach.

artículo científico publicado en 2006

The potential evasion of immune surveillance in mucosa associated lymphoid tissue lymphoma by DcR2-mediated up-regulation of nuclear factor-κB.

artículo científico publicado en 2014

The role of c-FLIP(L) in ovarian cancer: chaperoning tumor cells from immunosurveillance and increasing their invasive potential.

artículo científico publicado en 2010

Third consensus on medical treatment of metastatic breast cancer.

artículo científico publicado en 2009

Tissue Expression and Serum Levels of HER-2/neu in Patients with Breast Cancer ⬇️

artículo científico publicado el 1 de noviembre de 1997

Trail-induced apoptosis and interaction with cytotoxic agents in soft tissue sarcoma cell lines

artículo científico publicado en 2003

Transient increase in mitogen-induced lymphoproliferative responses in patients with testicular cancer after BEP chemotherapy.

artículo científico publicado en 2000

Tumor suppressor candidate 3 (TUSC3) prevents the epithelial-to-mesenchymal transition and inhibits tumor growth by modulating the endoplasmic reticulum stress response in ovarian cancer cells.

artículo científico publicado en 2015

[Genetic predisposition for breast carcinoma: overview of molecular genetic principles from long familial epidemiologic observation]

artículo científico publicado en 1995

[Germ cell tumors of the testis]

artículo científico publicado en 1994

[The significance of adhesion molecules in oncology]

scientific article published on 01 January 1995

[Therapy of castration-resistant prostate cancer]

artículo científico publicado en 2012

hVps37A Status affects prognosis and cetuximab sensitivity in ovarian cancer

artículo científico publicado en 2011

Lista de obras de Michael Krainer

32nd International Austrian Winter Symposium : Zell am See, the Netherlands. 20-23 January 2016

A prospective, open label, randomized phase II trial of weekly docetaxel versus weekly vinorelbine as first line chemotherapy in patients with androgen independent prostate cancer

Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.

BAMBI is overexpressed in ovarian cancer and co-translocates with Smads into the nucleus upon TGF-beta treatment

Chemotherapy for prostate cancer

Circulating endothelial progenitor cells in castration resistant prostate cancer: a randomized, controlled, biomarker study

Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database

Common death receptor 4 (DR4) polymorphisms do not predispose to ovarian cancer

Common nonsense mutations in RAD52

Contribution of epigenetic silencing of tumor necrosis factor-related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancer

Decreased expression of ICAM-1 and its induction by tumor necrosis factor on breast-cancer cells in vitro

Difference in patient's acceptance of early versus late initiation of psychosocial support in breast cancer.

Differential Contributions ofBRCA1andBRCA2to Early-Onset Breast Cancer

Distinctive outcome in patients with non-uterine and uterine leiomyosarcoma.

Docetaxel as rescue medication in anthracycline- and ifosfamide-resistant locally advanced or metastatic soft tissue sarcoma: results of a phase II trial

Docetaxel rechallenge after an initial good response in patients with metastatic castration-resistant prostate cancer.

Dose intensification of epidoxorubicin and cyclophosphamide in metastatic breast cancer: a randomised study with two schedules of granulocyte-macrophage colony stimulating factor

Epidermal growth factor receptor degradation: an alternative view of oncogenic pathways.

Erythropoietin treatment for chronic anemia of selected hematological malignancies and solid tumors

Erythropoietin treatment of chronic anaemia of cancer

Failure to confirm presence of SV40 sequences in human tumours.

Five genes from chromosomal band 8p22 are significantly down-regulated in ovarian carcinoma: N33 and EFA6R have a potential impact on overall survival

Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families

Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer

HCRP1 expression status is a significant prognostic marker in oral and oropharyngeal cancer

HIF1α Regulates mTOR Signaling and Viability of Prostate Cancer Stem Cells

High frequency of allelic imbalance at regions of chromosome arm 8p in ovarian carcinoma.

Hyperreactive cellular immunity in multiple myeloma

Immune checkpoint inhibitors in mCRPC - rationales, challenges and perspectives

In ovarian cancer the prognostic influence of HER2/neu is not dependent on the CXCR4/SDF-1 signalling pathway.

In vivo administration of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor increases neutrophil oxidative burst activity

Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome

Increase of bone marrow cellularity during erythropoietin treatment in myeloma

Increased natural killer cell activity correlates with low or negative expression of the HER-2/neu oncogene in patients with breast cancer

Influence of etoposide on the retention of radiolabeled low-density lipoprotein in the arterial wall

Influence of in vivo administration of GM-CSF and G-CSF on monocyte cytotoxicity

Interleukin-6 is a prognostic factor in multiple myeloma

Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial

Linking the ovarian cancer transcriptome and immunome

Loss of the oligosaccharyl transferase subunit TUSC3 promotes proliferation and migration of ovarian cancer cells.

Methylation status of TUSC3 is a prognostic factor in ovarian cancer

Monitoring of serum Her-2/neu predicts histopathological response to neoadjuvant trastuzumab-based therapy for breast cancer.

Monitoring of serum Her-2/neu predicts response and progression-free survival to trastuzumab-based treatment in patients with metastatic breast cancer

Natural killer cell activity in long-term survivors of testicular cancer. Influence of cytostatic therapy and initial stage of disease

Oncogenic BARD1 isoforms expressed in gynecological cancers

Perturbation of the tumor necrosis factor--related apoptosis-inducing ligand cascade in ovarian cancer: overexpression of FLIPL and deregulation of the functional receptors DR4 and DR5.

Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1.

Physical map and cosmid contig encompassing a new interstitial deletion of the X-linked lymphoproliferative syndrome region

Predictive value of interleukin-6 and neopterin in patients with multiple myeloma

Promoter hypermethylation of GSTP1, AR, and 14-3-3sigma in serum of prostate cancer patients and its clinical relevance

Rad52 gene mutations in breast/ovarian cancer families and sporadic ovarian carcinoma patients.

Recurrence-free survival in prostate cancer is related to increased stromal TRAIL expression.

Resistance to TRAIL-induced apoptosis in ovarian cancer cell lines is overcome by co-treatment with cytotoxic drugs.

Second consensus on medical treatment of metastatic breast cancer

Sequencing of Taxanes and New Androgen-targeted Therapies in Metastatic Castration-resistant Prostate Cancer: Results of the International Multicentre Retrospective CATS Database

Single-agent trastuzumab versus trastuzumab plus cytotoxic chemotherapy in metastatic breast cancer: a single-institution experience

Soluble HER-2/neu neutralizes biologic effects of anti-HER-2/neu antibody on breast cancer cells in vitro

Soluble ICAM-1 in breast cancer: clinical significance and biological implications.

TUSC3 loss alters the ER stress response and accelerates prostate cancer growth in vivo

Targeting signaling pathways in ovarian cancer.

Technetium-99m-tetrofosmin scintigraphy in patients with metastatic soft tissue sarcoma.

The European Society for Medical Oncology Magnitude of Clinical Benefit Scale in daily practice: a single institution, real-life experience at the Medical University of Vienna.

The Prognostic Value of C-Reactive Protein Serum Levels in Patients with Uterine Leiomyosarcoma.

The medical management of prostate cancer: a multidisciplinary team approach.

The potential evasion of immune surveillance in mucosa associated lymphoid tissue lymphoma by DcR2-mediated up-regulation of nuclear factor-κB.

The role of c-FLIP(L) in ovarian cancer: chaperoning tumor cells from immunosurveillance and increasing their invasive potential.

Third consensus on medical treatment of metastatic breast cancer.

Tissue Expression and Serum Levels of HER-2/neu in Patients with Breast Cancer ⬇️

Trail-induced apoptosis and interaction with cytotoxic agents in soft tissue sarcoma cell lines

Transient increase in mitogen-induced lymphoproliferative responses in patients with testicular cancer after BEP chemotherapy.

Tumor suppressor candidate 3 (TUSC3) prevents the epithelial-to-mesenchymal transition and inhibits tumor growth by modulating the endoplasmic reticulum stress response in ovarian cancer cells.

[Genetic predisposition for breast carcinoma: overview of molecular genetic principles from long familial epidemiologic observation]

[Germ cell tumors of the testis]

[The significance of adhesion molecules in oncology]

[Therapy of castration-resistant prostate cancer]

hVps37A Status affects prognosis and cetuximab sensitivity in ovarian cancer